Disparities in obstetric hemorrhage outcomes
Abstract Both the maternal and fetal outcomes of pregnancy vary greatly according to a pregnant woman’s community and her condition. The most devastating outcome is the death of a mother. In 2017, there were ≈295,000 maternal deaths globally with dramatic differences in maternal mortality based on g...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-01-01
|
| Series: | Research and Practice in Thrombosis and Haemostasis |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/rth2.12656 |
| _version_ | 1827832576833748992 |
|---|---|
| author | Andra H. James Jerome J. Federspiel Homa K. Ahmadzia |
| author_facet | Andra H. James Jerome J. Federspiel Homa K. Ahmadzia |
| author_sort | Andra H. James |
| collection | DOAJ |
| description | Abstract Both the maternal and fetal outcomes of pregnancy vary greatly according to a pregnant woman’s community and her condition. The most devastating outcome is the death of a mother. In 2017, there were ≈295,000 maternal deaths globally with dramatic differences in maternal mortality based on geographic region, country, and women’s underlying conditions. Worldwide, the leading cause of maternal death is hemorrhage, comprising 94% of maternal deaths, with most cases occurring in low‐ or middle‐income countries. Whether a hemorrhage originates from inside the uterus (80%‐90%), from lacerations or incisions (10%‐20%), or from an underlying coagulopathy (<1%), an acute acquired coagulopathy will evolve unless the hemorrhage is controlled. In low‐ or middle‐income countries, the full range of resources to control hemorrhage is not available, but besides the usual obstetric measures, blood availability, hemostatic medication, and hematologic expertise are necessary to save mothers’ lives. Hemostasis and thrombosis experts can address the disparities in obstetric hemorrhage outcomes not only as providers but as consultants, researchers, and advocates. |
| first_indexed | 2024-03-12T05:15:31Z |
| format | Article |
| id | doaj.art-4b2bebf8b4e440368993ba71f198c3e5 |
| institution | Directory Open Access Journal |
| issn | 2475-0379 |
| language | English |
| last_indexed | 2024-03-12T05:15:31Z |
| publishDate | 2022-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Research and Practice in Thrombosis and Haemostasis |
| spelling | doaj.art-4b2bebf8b4e440368993ba71f198c3e52023-09-03T08:07:21ZengElsevierResearch and Practice in Thrombosis and Haemostasis2475-03792022-01-0161n/an/a10.1002/rth2.12656Disparities in obstetric hemorrhage outcomesAndra H. James0Jerome J. Federspiel1Homa K. Ahmadzia2Department of Obstetrics and Gynecology Division of Maternal‐Fetal Medicine Duke University Durham North Carolina USADepartment of Obstetrics and Gynecology Division of Maternal‐Fetal Medicine Duke University Durham North Carolina USADepartment of Obstetrics and Gynecology Division of Maternal‐Fetal Medicine The George Washington University Washington District of Columbia USAAbstract Both the maternal and fetal outcomes of pregnancy vary greatly according to a pregnant woman’s community and her condition. The most devastating outcome is the death of a mother. In 2017, there were ≈295,000 maternal deaths globally with dramatic differences in maternal mortality based on geographic region, country, and women’s underlying conditions. Worldwide, the leading cause of maternal death is hemorrhage, comprising 94% of maternal deaths, with most cases occurring in low‐ or middle‐income countries. Whether a hemorrhage originates from inside the uterus (80%‐90%), from lacerations or incisions (10%‐20%), or from an underlying coagulopathy (<1%), an acute acquired coagulopathy will evolve unless the hemorrhage is controlled. In low‐ or middle‐income countries, the full range of resources to control hemorrhage is not available, but besides the usual obstetric measures, blood availability, hemostatic medication, and hematologic expertise are necessary to save mothers’ lives. Hemostasis and thrombosis experts can address the disparities in obstetric hemorrhage outcomes not only as providers but as consultants, researchers, and advocates.https://doi.org/10.1002/rth2.12656blood availabilitycoagulopathyhemorrhagematernal mortalitypregnancy |
| spellingShingle | Andra H. James Jerome J. Federspiel Homa K. Ahmadzia Disparities in obstetric hemorrhage outcomes Research and Practice in Thrombosis and Haemostasis blood availability coagulopathy hemorrhage maternal mortality pregnancy |
| title | Disparities in obstetric hemorrhage outcomes |
| title_full | Disparities in obstetric hemorrhage outcomes |
| title_fullStr | Disparities in obstetric hemorrhage outcomes |
| title_full_unstemmed | Disparities in obstetric hemorrhage outcomes |
| title_short | Disparities in obstetric hemorrhage outcomes |
| title_sort | disparities in obstetric hemorrhage outcomes |
| topic | blood availability coagulopathy hemorrhage maternal mortality pregnancy |
| url | https://doi.org/10.1002/rth2.12656 |
| work_keys_str_mv | AT andrahjames disparitiesinobstetrichemorrhageoutcomes AT jeromejfederspiel disparitiesinobstetrichemorrhageoutcomes AT homakahmadzia disparitiesinobstetrichemorrhageoutcomes |